Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M67.3Revenue (TTM) $M13.0Net Margin (%)586Altman Z-Score-12.6
Enterprise Value $M62.7EPS (TTM) $0.5Operating Margin %-54.0Piotroski F-Score7
P/E(ttm)0.9Beneish M-Score6.8Pre-tax Margin (%)-100.0Higher ROA y-yY
Price/Book4.110-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsN
Price/Sales5.05-y EBITDA Growth Rate %-42.2Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow1.1y-y EBITDA Growth Rate %--ROA % (ttm)419Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M162ROIC % (ttm)-245.2Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NAVB is held by these investors:



NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Regan William J.SVP & CCO 2017-06-29Buy20,000$0.53-20.75view
Latkin JedCOO and CFO 2017-05-30Buy7,600$0.44-4.55view
Latkin JedCOO and CFO 2017-05-22Buy25,359$0.45-6.67view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-12-01Sell12,500$1.5-72view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-11-02Sell12,500$1.98-78.79view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-10-01Sell12,500$2.27-81.5view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.88-77.66view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.71-75.44view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.24-66.13view
Troup Gordon ADirector 2015-05-29Buy10,000$1.31-67.94view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 

More From Other Websites
Navidea Biopharmaceuticals to Present at the Rodman & Renshaw 19th Annual Global Investment... Sep 08 2017
Navidea To Initiate Regular Webcast Series Featuring Moderated Q&A with Management Aug 30 2017
Edited Transcript of NAVB earnings conference call or presentation 9-Aug-17 12:00pm GMT Aug 16 2017
Navidea reports 2Q loss Aug 09 2017
Investor Network: Navidea Biopharmaceuticals, Inc. to Host Earnings Call Aug 09 2017
Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results Aug 08 2017
Navidea CEO: Splitting company could boost struggling stock Jul 14 2017
Navidea CEO to shareholders: Come up with a better idea for raising stock price Jul 10 2017
Navidea shareholders reject 1-for-20 reverse stock split, don't endorse director nominees Jul 05 2017
Navidea settles contested bill with PI that former CEO hired to investigate future CEO Jun 29 2017
Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics Jun 20 2017
Navidea getting new revenue source as cancer diagnostic aid launches in Europe Jun 12 2017
Navidea’s Commercial Partner, Norgine B.V., Launches LYMPHOSEEK® in Europe Jun 12 2017
ETFs with exposure to Navidea Biopharmaceuticals, Inc. : June 9, 2017 Jun 09 2017
Navidea Biopharmaceuticals to Present at the 7th Annual LD Micro Invitational Investor Conference Jun 01 2017
Navidea Biopharmaceuticals, Inc. :NAVB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 26, 2017 May 26 2017
Edited Transcript of NAVB earnings conference call or presentation 10-May-17 12:00pm GMT May 18 2017
Navidea pays former CEO $618,000 after losing arbitration over his firing May 18 2017
Navidea posts 1Q profit May 09 2017
Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results May 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}